参考资料:
[1]A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes.
[2]Non‐peptide agonists and positive allosteric modulators of glucagon‐like peptide‐1 receptors: Alternative approaches for treatment of Type 2 diabetes.